Clearline Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
706,112
+222,090
| +46% | +$3.72M | 0.44% | 40 |
|
|
2025
Q1 | $7.44M | Buy |
+484,022
| New | +$7.44M | 0.45% | 44 |
|
|
2024
Q3 | – | Sell |
-336,849
| Closed | -$5.47M | – | 168 |
|
|
2024
Q2 | $5.47M | Hold |
336,849
| – | – | 0.15% | 64 |
|
|
2024
Q1 | $4.75M | Sell |
336,849
-678,717
| -67% | -$9.58M | 0.23% | 56 |
|
|
2023
Q4 | $10.6M | Buy |
1,015,566
+288,770
| +40% | +$3.01M | 0.65% | 27 |
|
|
2023
Q3 | $7.41M | Sell |
726,796
-334,485
| -32% | -$3.41M | 0.64% | 40 |
|
|
2023
Q2 | $7.99M | Buy |
+1,061,281
| New | +$7.99M | 0.46% | 30 |
|
|
2015
Q3 | – | Sell |
-90,670
| Closed | -$5.36M | – | 63 |
|
|
2015
Q2 | $5.36M | Sell |
90,670
-190,306
| -68% | -$11.2M | 0.75% | 33 |
|
|
2015
Q1 | $17.5M | Hold |
280,976
| – | – | 2.62% | 16 |
|
|
2014
Q4 | $16.2M | Hold |
280,976
| – | – | 2.51% | 17 |
|
|
2014
Q3 | $15.1M | Hold |
280,976
| – | – | 2.43% | 19 |
|
|
2014
Q2 | $14.7M | Buy |
280,976
+28,055
| +11% | +$1.47M | 2.35% | 11 |
|
|
2014
Q1 | $13.4M | Buy |
+252,921
| New | +$13.4M | 3.04% | 11 |
|